Novartis AG Common Stock (NVS)

Other Income/Expenses (Net)

-$463.32M

Quarterly · Period ending: · USD

NVS logo

NVS Other Income/Expenses (Net)

Latest reported-$463.32M
NVS Quarterly Other Income/Expenses (Net) (-$5.70B → -$463.32M)
High-resolution chart · PNG

NVS other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-463,317,000
-396,000,000
-302,977,000
-305,000,000
-333,000,000
-256,000,000
-245,000,000
-242,000,000
-173,000,000
-244,000,000
-205,000,000
-210,000,000
-133,000,000
-98,000,000
-208,000,000
-239,000,000
-186,000,000
-183,000,000
14,389,000,000
-3,000,000
27,000,000
35,000,000
-85,000,000
-2,000,000
-64,000,000
-123,000,000
-64,000,000
49,000,000
-29,000,000
-102,000,000
-35,000,000
12,000,000
5,740,000,000
-31,000,000
231,000,000
79,000,000
35,000,000
25,000,000
-377,000,000
5,000,000
20,000,000
-99,000,000
-546,000,000
-65,000,000
-125,000,000
-107,000,000
405,000,000
793,000,000
-37,000,000
22,000,000
-51,000,000
-70,000,000
1,000,000
-57,000,000
-51,000,000
-167,000,000
27,000,000
-77,000,000
-56,000,000
-43,000,000
-76,000,000
-50,000,000
-47,000,000
207,000,000
-3,000,000
19,000,000
55,000,000
-143,000,000
79,000,000
-51,000,000
79,000,000
85,000,000
143,000,000
228,000,000
878,000,000
-468,000,000
-4,000,000
131,000,000
109,000,000
84,000,000
-259,000,000
154,000,000
110,000,000
83,000,000
89,000,000
78,000,000
83,000,000
147,000,000
76,000,000
63,000,000
46,000,000
79,000,000
123,000,000
-69,000,000
125,000,000
98,000,000
215,000,000
-4,858,000,000
9,805,000,000
-5,576,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.